Gulley Margaret L, Braziel Rita M, Halling Kevin C, Hsi Eric D, Kant Jeffrey A, Nikiforova Marina N, Nowak Jan A, Ogino Shuji, Oliveira Andre, Polesky Herbert F, Silverman Lawrence, Tubbs Raymond R, Van Deerlin Vivianna M, Vance Gail H, Versalovic James
Department of Pathology, 913 Brinkhous-Bullitt Bldg, University of North Carolina, Chapel Hill, NC 27599-7525, USA.
Arch Pathol Lab Med. 2007 Jun;131(6):852-63. doi: 10.5858/2007-131-852-CLRIMP.
Molecular pathology is a rapidly growing area of laboratory medicine in which DNA and RNA are analyzed. The recent introduction of array technology has added another layer of complexity involving massive parallel analysis of multiple genes, transcripts, or proteins.
As molecular technologies are increasingly implemented in clinical settings, it is important to bring uniformity to the way that test results are reported.
The College of American Pathologists Molecular Pathology Resource Committee members summarize elements that are already common to virtually all molecular pathology reports, as set forth in the College of American Pathologists checklists used in the laboratory accreditation process. Consensus recommendations are proposed to improve report format and content, and areas of controversy are discussed. Resources are cited that promote use of proper gene nomenclature and that describe methods for reporting mutations, translocations, microsatellite instability, and other genetic alterations related to inherited disease, cancer, identity testing, microbiology, and pharmacogenetics.
These resources and recommendations provide a framework for composing patient reports to convey molecular test results and their clinical significance to members of the health care team.
分子病理学是检验医学中一个快速发展的领域,主要对DNA和RNA进行分析。阵列技术的近期引入增加了另一层复杂性,涉及对多个基因、转录本或蛋白质的大规模平行分析。
随着分子技术在临床环境中的应用日益广泛,使检测结果的报告方式实现统一变得很重要。
美国病理学家学会分子病理学资源委员会成员总结了几乎所有分子病理学报告中已有的共同要素,这些要素在实验室认可过程中使用的美国病理学家学会清单中有阐述。提出了共识性建议以改进报告格式和内容,并讨论了存在争议的领域。引用了一些资源,这些资源促进了正确基因命名法的使用,并描述了报告突变、易位、微卫星不稳定性以及与遗传性疾病、癌症、身份检测、微生物学和药物遗传学相关的其他基因改变的方法。
这些资源和建议为撰写患者报告提供了一个框架,以便向医疗团队成员传达分子检测结果及其临床意义。